Literature DB >> 21129092

Satisfaction with physician recommendation for and information about genetic counseling among breast cancer patients.

Susan T Vadaparampil1, Gwendolyn P Quinn, Ji-Hyun Lee, Teri Malo, Xiuhua Zhao, Cheryl Miree, Jennifer Brzosowicz.   

Abstract

To evaluate satisfaction with (a) the timing and strength of provider recommendation for and (b) information received prior to and during genetic counseling (GC) among breast cancer patients who attended GC before definitive surgery (BDS) or after definitive surgery (ADS). Satisfaction with provider recommendation for and information received about GC was evaluated among breast cancer patients who attended GC as part of their clinical care (n=51). There were no significant differences among breast cancer patients who attended GC BDS or ADS in satisfaction with when the physician referred them for GC, the strength of recommendation for GC, the amount of information provided about the GC, and the information received in GC. From a clinical perspective, the optimal time for attending GC may be BDS. Nevertheless, breast cancer patients appear satisfied with physician recommendation of and information related to GC, regardless of when they attend.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21129092      PMCID: PMC4603559          DOI: 10.1111/j.1524-4741.2010.01027.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  10 in total

1.  Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.

Authors:  Jacek Gronwald; Nadine Tung; William D Foulkes; Kenneth Offit; Ruth Gershoni; Mary Daly; Charmaine Kim-Sing; Hakan Olsson; Peter Ainsworth; Andrea Eisen; Howard Saal; Eitan Friedman; Olufunmilayo Olopade; Michael Osborne; Jeffrey Weitzel; Henry Lynch; Parviz Ghadirian; Jan Lubinski; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

2.  Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.

Authors:  Marc D Schwartz; Caryn Lerman; Barbara Brogan; Beth N Peshkin; Claudine Isaacs; Tiffani DeMarco; Chanita Hughes Halbert; Marie Pennanen; Clinton Finch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

3.  The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

Authors:  Kelly A Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo A Olivotto; William D Foulkes; Ellen Warner; Olufunmilayo Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; Steven A Narod
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

4.  Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.

Authors:  Susan T Vadaparampil; Gwendolyn Pickard Quinn; Jennifer Brzosowicz; Cheryl A Miree
Journal:  J Psychosoc Oncol       Date:  2008

5.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

6.  Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.

Authors:  Susan T Vadaparampil; Gwendolyn P Quinn; Cheryl A Miree; Jennifer Brzosowicz; Bradford Carter; Christine Laronga
Journal:  Ann Surg Oncol       Date:  2009-04-30       Impact factor: 5.344

7.  Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Carla C Wárlám-Rodenhuis; Jan van den Bout; Margreet G E M Ausems
Journal:  Genet Med       Date:  2007-11       Impact factor: 8.822

8.  Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.

Authors:  Tiffani A DeMarco; Beth N Peshkin; Bryn D Mars; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2004-08       Impact factor: 2.537

9.  Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Authors:  Timothy R Rebbeck; Tara Friebel; Henry T Lynch; Susan L Neuhausen; Laura van 't Veer; Judy E Garber; Gareth R Evans; Steven A Narod; Claudine Isaacs; Ellen Matloff; Mary B Daly; Olufunmilayo I Olopade; Barbara L Weber
Journal:  J Clin Oncol       Date:  2004-02-23       Impact factor: 44.544

Review 10.  Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

Authors:  Bettina Meiser; Kathy Tucker; Michael Friedlander; Kristine Barlow-Stewart; Elizabeth Lobb; Christobel Saunders; Gillian Mitchell
Journal:  Breast Cancer Res       Date:  2008-11-28       Impact factor: 6.466

  10 in total
  8 in total

1.  Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.

Authors:  E Zilliacus; B Meiser; M Gleeson; K Watts; K Tucker; E A Lobb; G Mitchell
Journal:  Support Care Cancer       Date:  2012-03-24       Impact factor: 3.603

2.  Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.

Authors:  Akiva P Novetsky; Kylie Smith; Sheri A Babb; Donna B Jeffe; Andrea R Hagemann; Premal H Thaker; Matthew A Powell; David G Mutch; L Stewart Massad; Israel Zighelboim
Journal:  Int J Gynecol Cancer       Date:  2013-07       Impact factor: 3.437

Review 3.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

4.  Evaluation of a clinical genetics service--a quality initiative.

Authors:  Alison M Elliott; Bernard N Chodirker; Patricia Bocangel; Aizeddin A Mhanni
Journal:  J Genet Couns       Date:  2014-03-21       Impact factor: 2.537

5.  Exploring Prostate Cancer Patients' Interest and Preferences for Receiving Genetic Risk Information About Cancer Aggressiveness.

Authors:  Siddhartha Roy; Clement K Gwede; Teri L Malo; Courtney L Scherr; Selina Radlein; Cathy D Meade; Susan T Vadaparampil; Jong Y Park
Journal:  Am J Mens Health       Date:  2020 May-Jun

6.  Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients.

Authors:  Jeanine A M van der Giessen; Margreet G E M Ausems; Maria E T C van den Muijsenbergh; Sandra van Dulmen; Mirjam P Fransen
Journal:  Fam Cancer       Date:  2020-10       Impact factor: 2.375

Review 7.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

8.  "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.

Authors:  Adrianne R Mallen; Claire C Conley; Lindsay Fuzzell; Dana Ketcher; Bianca M Augusto; McKenzie McIntyre; Laura V Barton; Mary K Townsend; Brooke L Fridley; Shelley S Tworoger; Robert M Wenham; Susan T Vadaparampil
Journal:  Support Care Cancer       Date:  2020-09-25       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.